IRESSA tablets contain a medicine gefitinib which is a perfect inhibitor epidermal a receptor of the factor of growth (EGFR) tyrosine kinase.

IRESSA is used to consider patients with locally-advanced or metastatic or metastatic not a small cancer easy cells who has preliminary received chemotherapy or who is not suitable for chemotherapy.

EGFR tyrosine kinase - enzyme (chemical) which is usually expressed in a variety of firm human tumours. Forbidding activity of this enzyme, IRESSA slows down growth of a tumour, a metastasis (distribution of tumours from one part of a body to another) and angiogenesis (formation of courts of the fresh forces supporting growth of a tumour) and increases a cell of a tumour apoptosis (death of a cell).

IRESSA is accessible as tablet which can be taken with or without the foodstuffs.